OMA Guidelines Bundle

Obesity-Related Diseases 2026

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1544298

Contents of this Issue

Navigation

Page 42 of 45

43 Obesity and Musculoskeletal Conditions Osteoarthritis   ➤ Weight management, physical activity, and use of assistive devices are first-line interventions for reducing pain and improving physical function.   ➤ In individuals with obesity or overweight, weight loss of 10% can lead to a significant reduction in pain.   ➤ If nonpharmacologic measures do not control symptoms, then first-line therapy is nonsteroidal anti-inflammatory medications (topical or oral) at the lowest effective dose to control symptoms.   ➤ If medical management is not effective, consider referring to orthopedic surgery for total joint arthroplasty in advanced knee and hip osteoarthritis. Gout   ➤ Recommend limiting intake of alcohol, high-purine foods, animal proteins, high-fructose corn syrup, and sugar-sweetened beverages.   ➤ Recommend weight loss for individuals with gout and obesity or overweight.   ➤ Consider urate-lowering pharmacologic therapy for individuals with gout and subcutaneous tophi, radiographic changes due to gout, or two or more gout flares per year, advanced chronic kidney disease, a serum urate concentration greater than 9 mg/dL, or a history of urolithiasis.   ➤ Allopurinol is the preferred medication to reduce urate levels.

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity-Related Diseases 2026